Johannes Hulthe
Direttore/Membro del Consiglio presso GUARD THERAPEUTICS INTERNATIONAL AB
Profilo
Dr. Johannes Hulthe, MD, is an Independent Director at Lipigon Pharmaceuticals AB, an Independent Director at Guard Therapeutics International AB, a Chairman at Antaros Renostic AB and a Chief Executive Officer & Director at Antaros Medical AB.
He is on the Board of Directors at Lipigon Pharmaceuticals AB, Guard Therapeutics International AB, Antaros Medical AB, Antaros Holding AB and Metynex Pharmaceuticals AB.
Dr. Hulthe was previously employed as a Vice President by AstraZeneca AB.
He received his graduate degree from the University of Gothenburg and a doctorate degree from the University of Gothenburg.
Posizioni attive di Johannes Hulthe
| Società | Posizione | Inizio |
|---|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Direttore/Membro del Consiglio | 29/05/2019 |
| LIPIGON PHARMACEUTICALS AB | Direttore/Membro del Consiglio | 01/01/2020 |
Antaros Medical AB
 Antaros Medical AB Miscellaneous Commercial ServicesCommercial Services Antaros Medical AB provides scientific, technical, research and development services. The private company is based in Stockholm, Sweden. The Swedish company was founded by Johannes Hulthe. Johannes Hulthe has been the CEO since incorporation. | Fondatore | - |
| Antaros Renostic AB | Presidente | - |
| Antaros Holding AB | Direttore/Membro del Consiglio | - |
| Metynex Pharmaceuticals AB | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Johannes Hulthe
| Società | Posizione | Fine |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 01/01/2014 |
Formazione di Johannes Hulthe
| University of Gothenburg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Health Technology |
| LIPIGON PHARMACEUTICALS AB | Health Technology |
| Aziende private | 5 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Antaros Medical AB
Antaros Medical AB Miscellaneous Commercial ServicesCommercial Services Antaros Medical AB provides scientific, technical, research and development services. The private company is based in Stockholm, Sweden. The Swedish company was founded by Johannes Hulthe. Johannes Hulthe has been the CEO since incorporation. | Commercial Services |
| Antaros Renostic AB | |
| Antaros Holding AB | |
| Metynex Pharmaceuticals AB |
- Borsa valori
- Insiders
- Johannes Hulthe
